The proteasome complex is a broad spectrum protease present in all eukaryotes, which functions to carry out selective, efficient and progressive hydrolysis of intracellular target proteins. The proteasome plays a prominent role in the control of a diverse array of basic cellular processes by rapidly catalyzing numerous biological reactions.
The proteasome complex is composed of a 20S catalytic core and one or two terminal 19S regulatory units. The 20S catalytic domain is barrel-shaped and consists of seven structurally similar α- and β-subunits. In the inactive state, the external α-subunits act as a physical barrier to prevent peptide substrates accessing the active site on the β-subunits. The 19S regulatory units recognize proteins marked by polyubiquitin chains, remove the chain, entrap the protein moiety and open the 20S α-subunits allowing the β-subunits to degrade the protein. Assembly of the 20S domain is very complex and requires extrinsic (eg PAC1) and intrinsic (eg C-tail of β-subunits) chaperones. The assembly mechanism of the 19S domain is poorly understood, but Hsp90 is thought to play a role.
Regulation of the proteasome complex is mediated by proteasome interacting proteins (PIPs). There are two classes of PIPs; protein factors related to the ubiquitylation system such as the deubiquitylating enzyme, Usp14 and auxillary factors that regulate proteasome functions via direct binding, for example Ecm29.View all products for Proteasome »
|Gene||Species||Gene Symbol||Gene Accession No.||Protein Accession No.|
|View all Proteasome Gene Data »|
Literature for Proteasome
Cancer Research Guide
Find multiple products by catalog number
Potent, selective LRRK2 inhibitor
Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.